Lada Artem G, Kliver Sergei F, Dhar Alok, Polev Dmitrii E, Masharsky Alexey E, Rogozin Igor B, Pavlov Youri I
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Department of Genetics and Biotechnology, Saint Petersburg State University, St. Petersburg, Russia.
PLoS Genet. 2015 May 5;11(5):e1005217. doi: 10.1371/journal.pgen.1005217. eCollection 2015 May.
Mutations in genomes of species are frequently distributed non-randomly, resulting in mutation clusters, including recently discovered kataegis in tumors. DNA editing deaminases play the prominent role in the etiology of these mutations. To gain insight into the enigmatic mechanisms of localized hypermutagenesis that lead to cluster formation, we analyzed the mutational single nucleotide variations (SNV) data obtained by whole-genome sequencing of drug-resistant mutants induced in yeast diploids by AID/APOBEC deaminase and base analog 6-HAP. Deaminase from sea lamprey, PmCDA1, induced robust clusters, while 6-HAP induced a few weak ones. We found that PmCDA1, AID, and APOBEC1 deaminases preferentially mutate the beginning of the actively transcribed genes. Inactivation of transcription initiation factor Sub1 strongly reduced deaminase-induced can1 mutation frequency, but, surprisingly, did not decrease the total SNV load in genomes. However, the SNVs in the genomes of the sub1 clones were re-distributed, and the effect of mutation clustering in the regions of transcription initiation was even more pronounced. At the same time, the mutation density in the protein-coding regions was reduced, resulting in the decrease of phenotypically detected mutants. We propose that the induction of clustered mutations by deaminases involves: a) the exposure of ssDNA strands during transcription and loss of protection of ssDNA due to the depletion of ssDNA-binding proteins, such as Sub1, and b) attainment of conditions favorable for APOBEC action in subpopulation of cells, leading to enzymatic deamination within the currently expressed genes. This model is applicable to both the initial and the later stages of oncogenic transformation and explains variations in the distribution of mutations and kataegis events in different tumor cells.
物种基因组中的突变常常呈非随机分布,从而形成突变簇,包括最近在肿瘤中发现的kataegis现象。DNA编辑脱氨酶在这些突变的病因学中起着重要作用。为了深入了解导致簇形成的局部高突变的神秘机制,我们分析了通过对由AID/APOBEC脱氨酶和碱基类似物6-HAP诱导的酵母二倍体中的耐药突变体进行全基因组测序获得的突变单核苷酸变异(SNV)数据。来自海七鳃鳗的脱氨酶PmCDA1诱导出强大的簇,而6-HAP诱导出一些较弱的簇。我们发现PmCDA1、AID和APOBEC1脱氨酶优先使活跃转录基因的起始部位发生突变。转录起始因子Sub1的失活强烈降低了脱氨酶诱导的can1突变频率,但令人惊讶的是,并没有降低基因组中的总SNV负荷。然而,sub1克隆基因组中的SNV重新分布,并且转录起始区域中突变簇的效应更加明显。同时,蛋白质编码区域中的突变密度降低,导致表型检测到的突变体减少。我们提出,脱氨酶诱导的簇状突变涉及:a)转录过程中ssDNA链的暴露以及由于ssDNA结合蛋白(如Sub1)的消耗导致的ssDNA保护丧失,以及b)在细胞亚群中达到有利于APOBEC作用的条件,导致当前表达基因内的酶促脱氨。该模型适用于致癌转化的初始阶段和后期阶段,并解释了不同肿瘤细胞中突变和kataegis事件分布的差异。